CLINICAL_TRIALS
trial_result
· 2013-04-02
Clinical Trial Update: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on) [Phase 3]
Summary
A Phase 3 add-on trial of lurasidone for bipolar I depression has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2013-04-02